Matzim La Tablet, Extended Release
Product Images NDC 52544-694
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Matzim La (NDC 52544-694). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image 10
Image 11
Image 12
Image 13
Image 14
Image 15
This is a description of Matzim°LA, which is Diltiazem Hydrochloride in the form of Extended-Release Tablets. Each bottle contains 30 tablets, and the recommended dosage is one tablet per day. The tablets are manufactured by Actavis ROy and each extended-release tablet contains 389 milligrams of Diltiazem Hydrochloride. The bottle has a warning to keep it out of reach of children and store it between 20°C to 25°C. There are some illegible characters towards the end.*
Image 16
Image 2
Image 3
Image 4
Image 5
Image 6
Image 7
Image 8
Image 9
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.